{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:28:26Z","timestamp":1768271306579,"version":"3.49.0"},"publisher-location":"Singapore","reference-count":173,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789811973758","type":"print"},{"value":"9789811973765","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-19-7376-5_19","type":"book-chapter","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:03:57Z","timestamp":1679504637000},"page":"435-458","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti-Inflammatory Effect of Traditional Chinese Medicine on the Concept of Mind-Body Interface"],"prefix":"10.1007","author":[{"given":"Sheng-Ta","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasan","family":"Nithiyanantham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthil Kumaran","family":"Satyanarayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Pin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2019.07.011","volume":"82","author":"KP Su","year":"2019","unstructured":"Su KP. Are we all the same? The critical role of translational brain, behavior, and immunity research in East Asia. Brain Behav Immun. 2019;82:1\u20132.","journal-title":"Brain Behav Immun"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-981-13-0971-7_4","volume-title":"Experimental Acupuncturology","author":"K-P Su","year":"2018","unstructured":"Su K-P, Chou L-W, Sun M-F, Lin J-G. Acupuncture treatment in depression. In: Lin J-G, editor. Experimental Acupuncturology. Singapore: Springer Singapore; 2018. p. 43\u201366."},{"key":"19_CR3","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference. Acupuncture. JAMA. 1998;280(17):1518\u201324.","DOI":"10.1001\/jama.280.17.1518"},{"issue":"5","key":"19_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0029-1202263","volume":"42","author":"C Song","year":"2009","unstructured":"Song C, Halbreich U, Han C, Leonard BE, Luo H. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry. 2009;42(5):182\u20138.","journal-title":"Pharmacopsychiatry"},{"key":"19_CR5","first-page":"21","volume":"34","author":"RD V\u00e1zquez","year":"2011","unstructured":"V\u00e1zquez RD, Gonz\u00e1lez-Mac\u00edas L, Berlanga C, Aedo FJ. Effect of acupuncture treatment on depression: correlation between psychological outcomes and salivary cortisol levels. Salud mental. 2011;34:21\u20136.","journal-title":"Salud mental"},{"issue":"5","key":"19_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0254-6272(15)30132-1","volume":"35","author":"Y Liu","year":"2015","unstructured":"Liu Y, Feng H, Mo Y, Gao J, Mao H, Song M, et al. Effect of soothing-liver and nourishing-heart acupuncture on early selective serotonin reuptake inhibitor treatment onset for depressive disorder and related indicators of neuroimmunology: a randomized controlled clinical trial. J Tradit Chin Med. 2015;35(5):507\u201313.","journal-title":"J Tradit Chin Med"},{"key":"19_CR7","first-page":"6","volume":"22","author":"H-L Chen","year":"2016","unstructured":"Chen H-L, Guan F. Effect of Huanglian jiedu decoction on pitavastatin treatment of Alzheimer\u2019s disease. Journal of Hainan Medical University. 2016;22:6.","journal-title":"Journal of Hainan Medical University"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"692795","DOI":"10.1155\/2015\/692795","volume":"2015","author":"F Wang","year":"2015","unstructured":"Wang F, Sun L, Zhang XZ, Jia J, Liu Z, Huang XY, et al. Effect and potential mechanism of Electroacupuncture add-on treatment in patients with Parkinson\u2019s disease. Evid Based Complement Alternat Med. 2015;2015:692795.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"19_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.9758\/cpn.2021.19.2.190","volume":"19","author":"PH Chou","year":"2021","unstructured":"Chou PH, Lin YF, Lu MK, Chang HA, Chu CS, Chang WH, et al. Personalization of repetitive transcranial magnetic stimulation for the treatment of major depressive disorder according to the existing psychiatric comorbidity. Clin Psychopharmacol Neurosci. 2021;19(2):190\u2013205.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"Suppl 6","key":"19_CR10","first-page":"7","volume":"61","author":"PL Delgado","year":"2000","unstructured":"Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psychiatry. 2000;61(Suppl 6):7\u201311.","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"19_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/2045125317737264","volume":"8","author":"SS Clevenger","year":"2018","unstructured":"Clevenger SS, Malhotra D, Dang J, Vanle B, IsHak WW. The role of selective serotonin reuptake inhibitors in preventing relapse of major depressive disorder. Ther Adv Psychopharmacol. 2018;8(1):49\u201358.","journal-title":"Ther Adv Psychopharmacol"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2147\/JIR.S141033","volume":"11","author":"SW Jeon","year":"2018","unstructured":"Jeon SW, Kim YK. The role of neuroinflammation and neurovascular dysfunction in major depressive disorder. J Inflamm Res. 2018;11:179\u201392.","journal-title":"J Inflamm Res"},{"issue":"5","key":"19_CR13","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1210\/jc.2004-1667","volume":"90","author":"S Alesci","year":"2005","unstructured":"Alesci S, Martinez PE, Kelkar S, Ilias I, Ronsaville DS, Listwak SJ, et al. Major depression is associated with significant diurnal elevations in plasma Interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metabol. 2005;90(5):2522\u201330.","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"19_CR14","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446\u201357.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"19_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009;71(2):171\u201386.","journal-title":"Psychosom Med"},{"issue":"4","key":"19_CR16","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","volume":"22","author":"S Lanquillon","year":"2000","unstructured":"Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22(4):370\u20139.","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"19_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732\u201341.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"19_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24\u201331.","journal-title":"Trends Immunol"},{"issue":"2","key":"19_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/PSY.0b013e31819082ef","volume":"71","author":"S Su","year":"2009","unstructured":"Su S, Miller AH, Snieder H, Bremner JD, Ritchie J, Maisano C, et al. Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the twins heart study. Psychosom Med. 2009;71(2):152\u20138.","journal-title":"Psychosom Med"},{"issue":"3","key":"19_CR20","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/00048670601057759","volume":"41","author":"K Yang","year":"2007","unstructured":"Yang K, Xie G, Zhang Z, Wang C, Li W, Zhou W, et al. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust N Z J Psychiatry. 2007;41(3):266\u201373.","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"19_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","volume":"170","author":"C Tuglu","year":"2003","unstructured":"Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl). 2003;170(4):429\u201333.","journal-title":"Psychopharmacology (Berl)"},{"issue":"8","key":"19_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1017\/S1092852900020393","volume":"14","author":"M Clerici","year":"2009","unstructured":"Clerici M, Arosio B, Mundo E, Cattaneo E, Pozzoli S, Dell'osso B, et al. Cytokine polymorphisms in the pathophysiology of mood disorders. CNS Spectr. 2009;14(8):419\u201325.","journal-title":"CNS Spectr"},{"issue":"8","key":"19_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/mp.2008.59","volume":"13","author":"ML Wong","year":"2008","unstructured":"Wong ML, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry. 2008;13(8):800\u201312.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"19_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/1319-3767.27847","volume":"12","author":"Y Al-Huthail","year":"2006","unstructured":"Al-Huthail Y. Neuropsychiatric side-effects of interferon alfa therapy for hepatitis C and their management: a review. Saudi J Gastroenterol. 2006;12(2):59\u201367.","journal-title":"Saudi J Gastroenterol"},{"issue":"3","key":"19_CR25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/00006842-200105000-00007","volume":"63","author":"L Capuron","year":"2001","unstructured":"Capuron L, Ravaud A, Dantzer R. Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med. 2001;63(3):376\u201386.","journal-title":"Psychosom Med"},{"issue":"6103","key":"19_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1126\/science.1222941","volume":"338","author":"AJ Eisch","year":"2012","unstructured":"Eisch AJ, Petrik D. Depression and hippocampal neurogenesis: a road to remission? Science. 2012;338(6103):72\u20135.","journal-title":"Science"},{"issue":"1","key":"19_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbi.2006.08.009","volume":"21","author":"TW Pace","year":"2007","unstructured":"Pace TW, Hu F, Miller AH. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun. 2007;21(1):9\u201319.","journal-title":"Brain Behav Immun"},{"issue":"8","key":"19_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0306-4530(95)00011-9","volume":"20","author":"EB De Souza","year":"1995","unstructured":"De Souza EB. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 1995;20(8):789\u2013819.","journal-title":"Psychoneuroendocrinology"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.neubiorev.2013.11.009","volume":"38","author":"I Mahar","year":"2014","unstructured":"Mahar I, Bambico FR, Mechawar N, Nobrega JN. Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev. 2014;38:173\u201392.","journal-title":"Neurosci Biobehav Rev"},{"key":"19_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","volume":"64","author":"YK Kim","year":"2016","unstructured":"Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:277\u201384.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"13","key":"19_CR31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1212\/WNL.0000000000004411","volume":"89","author":"S Rossi","year":"2017","unstructured":"Rossi S, Studer V, Motta C, Polidoro S, Perugini J, Macchiarulo G, et al. Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis. Neurology. 2017;89(13):1338\u201347.","journal-title":"Neurology"},{"issue":"6","key":"19_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2217\/ijr.11.62","volume":"6","author":"M Margaretten","year":"2011","unstructured":"Margaretten M, Julian L, Katz P, Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int J Clin Rheumtol. 2011;6(6):617\u201323.","journal-title":"Int J Clin Rheumtol"},{"issue":"28","key":"19_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011376","volume":"97","author":"M Figueiredo-Braga","year":"2018","unstructured":"Figueiredo-Braga M, Cornaby C, Cortez A, Bernardes M, Terroso G, Figueiredo M, et al. Depression and anxiety in systemic lupus erythematosus: the crosstalk between immunological, clinical, and psychosocial factors. Medicine (Baltimore). 2018;97(28):e11376.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"19_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1017\/S1461145702003152","volume":"5","author":"Y Pollak","year":"2002","unstructured":"Pollak Y, Yirmiya R. Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol. 2002;5(4):389\u201399.","journal-title":"Int J Neuropsychopharmacol"},{"key":"19_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pnpbp.2014.10.003","volume":"57","author":"HA Eyre","year":"2015","unstructured":"Eyre HA, Air T, Proctor S, Rositano S, Baune BT. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2015;57:11\u20136.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"19_CR36","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1017\/S1461145710000970","volume":"13","author":"B Garc\u00eda-Bueno","year":"2010","unstructured":"Garc\u00eda-Bueno B, P\u00e9rez-Nievas BG, Leza JC. Is there a role for the nuclear receptor PPAR\u03b3 in neuropsychiatric diseases? Int J Neuropsychopharmacol. 2010;13(10):1411\u201329.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"19_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pnpbp.2012.06.003","volume":"39","author":"D Johansson","year":"2012","unstructured":"Johansson D, Falk A, Marcus MM, Svensson TH. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(1):143\u20138.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"12","key":"19_CR38","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat. 2014;71(12):1381\u201391.","journal-title":"JAMA Psychiat"},{"issue":"7","key":"19_CR39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1517\/14656566.7.7.837","volume":"7","author":"M Krebs","year":"2006","unstructured":"Krebs M, Leopold K, Hinzpeter A, Schaefer M. Neuroprotective agents in schizophrenia and affective disorders. Expert Opin Pharmacother. 2006;7(7):837\u201348.","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"19_CR40","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N M\u00fcller","year":"2006","unstructured":"M\u00fcller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-M\u00fcller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006;11(7):680\u20134.","journal-title":"Mol Psychiatry"},{"key":"19_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-10-43","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation. 2013;10:43.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"19_CR42","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hup.912","volume":"23","author":"FG Nery","year":"2008","unstructured":"Nery FG, Monkul ES, Hatch JP, Fonseca M, Zunta-Soares GB, Frey BN, et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol. 2008;23(2):87\u201394.","journal-title":"Hum Psychopharmacol"},{"issue":"3","key":"19_CR43","first-page":"288","volume":"26","author":"FM Schmidt","year":"2014","unstructured":"Schmidt FM, Kirkby KC, Himmerich H. The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression\u2014report of two cases. Psychiatr Danub. 2014;26(3):288\u201390.","journal-title":"Psychiatr Danub"},{"issue":"2","key":"19_CR44","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1176\/ajp.2007.164.2.201","volume":"164","author":"AJ Rush","year":"2007","unstructured":"Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007;164(2):201\u20134.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"19_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28\u201340.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"19_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3949\/ccjm.75.1.57","volume":"75","author":"BN Gaynes","year":"2008","unstructured":"Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Spencer D, Fava M. The STAR*D study: treating depression in the real world. Cleve Clin J Med. 2008;75(1):57\u201366.","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"19_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/070674371005500303","volume":"55","author":"M Sinyor","year":"2010","unstructured":"Sinyor M, Schaffer A, Levitt A. The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review. Can J Psychiatry. 2010;55(3):126\u201335.","journal-title":"Can J Psychiatry"},{"key":"19_CR48","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jad.2015.03.031","volume":"179","author":"D Solomon","year":"2015","unstructured":"Solomon D, Adams J. The use of complementary and alternative medicine in adults with depressive disorders. A critical integrative review. J Affect Disord. 2015;179:101\u201313.","journal-title":"J Affect Disord"},{"issue":"2","key":"19_CR49","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1176\/appi.ajp.158.2.289","volume":"158","author":"RC Kessler","year":"2001","unstructured":"Kessler RC, Soukup J, Davis RB, Foster DF, Wilkey SA, Van Rompay MI, et al. The use of complementary and alternative therapies to treat anxiety and depression in the United States. Am J Psychiatry. 2001;158(2):289\u201394.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"19_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jad.2008.03.010","volume":"111","author":"M-C Hsu","year":"2008","unstructured":"Hsu M-C, Creedy D, Moyle W, Venturato L, Tsay S-L, Ouyang W-C. Use of complementary and alternative medicine among adult patients for depression in Taiwan. J Affect Disord. 2008;111(2):360\u20135.","journal-title":"J Affect Disord"},{"key":"19_CR51","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2147\/NDT.S43419","volume":"9","author":"NA Qureshi","year":"2013","unstructured":"Qureshi NA, Al-Bedah AM. Mood disorders and complementary and alternative medicine: a literature review. Neuropsychiatr Dis Treat. 2013;9:639\u201358.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"19_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/160189","volume":"2015","author":"WF Yeung","year":"2015","unstructured":"Yeung WF, Chung KF, Ng KY, Yu YM, Zhang SP, Ng BF, et al. Prescription of Chinese herbal medicine in pattern-based traditional Chinese medicine treatment for depression: a systematic review. Evid Based Complement Alternat Med. 2015;2015:160189.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"19_CR53","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/13880209.2011.602696","volume":"50","author":"QQ Mao","year":"2012","unstructured":"Mao QQ, Ip SP, Xian YF, Hu Z, Che CT. Anti-depressant-like effect of peony: a mini-review. Pharm Biol. 2012;50(1):72\u20137.","journal-title":"Pharm Biol"},{"issue":"9","key":"19_CR54","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.vaccine.2005.09.030","volume":"24","author":"HX Sun","year":"2006","unstructured":"Sun HX. Haemolytic activities and adjuvant effect of Bupleurum chinense saponins on the immune responses to ovalbumin in mice. Vaccine. 2006;24(9):1324\u201331.","journal-title":"Vaccine"},{"key":"19_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/902578","volume":"2012","author":"WF Yeung","year":"2012","unstructured":"Yeung WF, Chung KF, Poon MM, Ho FY, Zhang SP, Zhang ZJ, et al. Prescription of chinese herbal medicine and selection of acupoints in pattern-based traditional chinese medicine treatment for insomnia: a systematic review. Evid Based Complement Alternat Med. 2012;2012:902578.","journal-title":"Evid Based Complement Alternat Med"},{"key":"19_CR56","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.bbi.2019.08.190","volume":"82","author":"SK Satyanarayanan","year":"2019","unstructured":"Satyanarayanan SK, Shih Y-H, Wen Y-R, Palani M, Lin Y-W, Su H, et al. miR-200a-3p modulates gene expression in comorbid pain and depression: molecular implication for central sensitization. Brain Behav Immun. 2019;82:230\u20138.","journal-title":"Brain Behav Immun"},{"key":"19_CR57","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbi.2020.06.033","volume":"89","author":"Y-W Lin","year":"2020","unstructured":"Lin Y-W, Chou AIW, Su H, Su K-P. Transient receptor potential V1 (TRPV1) modulates the therapeutic effects for comorbidity of pain and depression: the common molecular implication for electroacupuncture and omega-3 polyunsaturated fatty acids. Brain Behav Immun. 2020;89:604\u201314.","journal-title":"Brain Behav Immun"},{"issue":"Suppl","key":"19_CR58","doi-asserted-by":"publisher","first-page":"S338","DOI":"10.1111\/j.1440-1819.1998.tb03262.x","volume":"52","author":"H Luo","year":"1998","unstructured":"Luo H, Meng F, Jia Y, Zhao X. Clinical research on the therapeutic effect of the electro-acupuncture treatment in patients with depression. Psychiatry Clin Neurosci. 1998;52(Suppl):S338\u201340.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"9","key":"19_CR59","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/acm.2011.0637","volume":"19","author":"H Sun","year":"2013","unstructured":"Sun H, Zhao H, Ma C, Bao F, Zhang J, Wang DH, et al. Effects of electroacupuncture on depression and the production of glial cell line-derived neurotrophic factor compared with fluoxetine: a randomized controlled pilot study. J Altern Complement Med. 2013;19(9):733\u20139.","journal-title":"J Altern Complement Med"},{"issue":"2\u20133","key":"19_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jad.2012.11.058","volume":"148","author":"I Quah-Smith","year":"2013","unstructured":"Quah-Smith I, Smith C, Crawford JD, Russell J. Laser acupuncture for depression: a randomised double blind controlled trial using low intensity laser intervention. J Affect Disord. 2013;148(2\u20133):179\u201387.","journal-title":"J Affect Disord"},{"issue":"3","key":"19_CR61","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/aim.23.3.103","volume":"23","author":"JI Quah-Smith","year":"2005","unstructured":"Quah-Smith JI, Tang WM, Russell J. Laser acupuncture for mild to moderate depression in a primary care setting\u2014a randomised controlled trial. Acupunct Med. 2005;23(3):103\u201311.","journal-title":"Acupunct Med"},{"key":"19_CR62","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1472-6882-14-255","volume":"14","author":"SC Man","year":"2014","unstructured":"Man SC, Hung BH, Ng RM, Yu XC, Cheung H, Fung MP, et al. A pilot controlled trial of a combination of dense cranial electroacupuncture stimulation and body acupuncture for post-stroke depression. BMC Complement Altern Med. 2014;14:255.","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"19_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0254-6272(12)60024-7","volume":"32","author":"GC Zhang","year":"2012","unstructured":"Zhang GC, Fu WB, Xu NG, Liu JH, Zhu XP, Liang ZH, et al. Meta analysis of the curative effect of acupuncture on post-stroke depression. J Tradit Chin Med. 2012;32(1):6\u201311.","journal-title":"J Tradit Chin Med"},{"issue":"1","key":"19_CR64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1142\/S0192415X08005618","volume":"36","author":"PJ Chen","year":"2008","unstructured":"Chen PJ, Hsieh CL, Su KP, Hou YC, Chiang HM, Lin IH, et al. The antidepressant effect of Gastrodia elata Bl. On the forced-swimming test in rats. Am J Chin Med. 2008;36(1):95\u2013106.","journal-title":"Am J Chin Med"},{"issue":"6","key":"19_CR65","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1142\/S0192415X09007533","volume":"37","author":"PJ Chen","year":"2009","unstructured":"Chen PJ, Hsieh CL, Su KP, Hou YC, Chiang HM, Sheen LY. Rhizomes of Gastrodia elata B(L) possess antidepressant-like effect via monoamine modulation in subchronic animal model. Am J Chin Med. 2009;37(6):1113\u201324.","journal-title":"Am J Chin Med"},{"issue":"6","key":"19_CR66","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1089\/jmf.2010.1209","volume":"14","author":"PJ Chen","year":"2011","unstructured":"Chen PJ, Liang KC, Lin HC, Hsieh CL, Su KP, Hung MC, et al. Gastrodia elata Bl. Attenuated learning deficits induced by forced-swimming stress in the inhibitory avoidance task and Morris water maze. J Med Food. 2011;14(6):610\u20137.","journal-title":"J Med Food"},{"issue":"1","key":"19_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/2225-4110.106548","volume":"3","author":"SH Lin","year":"2013","unstructured":"Lin SH, Chang HC, Chen PJ, Hsieh CL, Su KP, Sheen LY. The antidepressant-like effect of ethanol extract of daylily flowers (J\u012bn Zh\u0113n Hu\u0101) in rats. J Tradit Complement Med. 2013;3(1):53\u201361.","journal-title":"J Tradit Complement Med"},{"issue":"6","key":"19_CR68","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1142\/S0192415X2150066X","volume":"49","author":"HY Liao","year":"2021","unstructured":"Liao HY, Lin YW. Electroacupuncture attenuates chronic inflammatory pain and depression comorbidity through transient receptor potential V1 in the brain. Am J Chin Med. 2021;49(6):1417\u201335.","journal-title":"Am J Chin Med"},{"issue":"38","key":"19_CR69","doi-asserted-by":"publisher","first-page":"631770","DOI":"10.3389\/fnagi.2021.631770","volume":"13","author":"JA Santiago","year":"2021","unstructured":"Santiago JA, Potashkin JA. The impact of disease comorbidities in Alzheimer\u2019s disease. Front Aging Neurosci. 2021;13(38):631770.","journal-title":"Front Aging Neurosci"},{"key":"19_CR70","doi-asserted-by":"crossref","unstructured":"2020 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2020;16(3):391\u2013460.","DOI":"10.1002\/alz.12068"},{"issue":"18","key":"19_CR71","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1056\/NEJMe2103722","volume":"384","author":"AI Levey","year":"2021","unstructured":"Levey AI. Progress with treatments for Alzheimer\u2019s disease. N Engl J Med. 2021;384(18):1762\u20133.","journal-title":"N Engl J Med"},{"key":"19_CR72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13020-016-0086-9","volume":"11","author":"SK Lin","year":"2016","unstructured":"Lin SK, Yan SH, Lai JN, Tsai TH. Patterns of Chinese medicine use in prescriptions for treating Alzheimer's disease in Taiwan. Chinas Med. 2016;11:12.","journal-title":"Chinas Med"},{"key":"19_CR73","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/642128","volume":"2014","author":"P Liu","year":"2014","unstructured":"Liu P, Kong M, Yuan S, Liu J, Wang P. History and experience: a survey of traditional chinese medicine treatment for Alzheimer's disease. Evid Based Complement Alternat Med. 2014;2014:642128.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"11","key":"19_CR74","first-page":"541","volume":"88","author":"S Cavalieri","year":"1997","unstructured":"Cavalieri S, Rotoli M. Huangdi Neijing: a classic book of traditional Chinese medicine. Recenti Prog Med. 1997;88(11):541\u20136.","journal-title":"Recenti Prog Med"},{"issue":"13","key":"19_CR75","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.4103\/0366-6999.235112","volume":"131","author":"YG Chen","year":"2018","unstructured":"Chen YG. Research Progress in the pathogenesis of Alzheimer's disease. Chin Med J (Engl). 2018;131(13):1618\u201324.","journal-title":"Chin Med J (Engl)"},{"key":"19_CR76","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/743541","volume":"2014","author":"B Yu","year":"2014","unstructured":"Yu B, Zhou C, Zhang J, Ling Y, Hu Q, Wang Y, et al. Latest study on the relationship between pathological process of inflammatory injury and the syndrome of spleen deficiency and fluid retention in Alzheimer's disease. Evid Based Complement Alternat Med. 2014;2014:743541.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"2","key":"19_CR77","doi-asserted-by":"publisher","first-page":"307","DOI":"10.14336\/AD.2018.0328","volume":"10","author":"SG Jeon","year":"2019","unstructured":"Jeon SG, Song EJ, Lee D, Park J, Nam Y, Kim JI, et al. Traditional oriental medicines and Alzheimer's disease. Aging Dis. 2019;10(2):307\u201328.","journal-title":"Aging Dis"},{"issue":"1","key":"19_CR78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jams.2012.11.009","volume":"6","author":"BH May","year":"2013","unstructured":"May BH, Lu C, Lu Y, Zhang AL, Xue CC. Chinese herbs for memory disorders: a review and systematic analysis of classical herbal literature. J Acupunct Meridian Stud. 2013;6(1):2\u201311.","journal-title":"J Acupunct Meridian Stud"},{"key":"19_CR79","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jep.2014.12.015","volume":"161","author":"SK Lin","year":"2015","unstructured":"Lin SK, Tsai YT, Lai JN, Wu CT. Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: a nationwide database study. J Ethnopharmacol. 2015;161:108\u201315.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"19_CR80","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013931","volume":"98","author":"SK Lin","year":"2019","unstructured":"Lin SK, Tzeng JN, Lai JN. The core pattern of Chinese herbal formulae and drug-herb concurrent usage in patients with dementia. Medicine (Baltimore). 2019;98(4):e13931.","journal-title":"Medicine (Baltimore)"},{"issue":"Pt A","key":"19_CR81","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jep.2014.10.024","volume":"158","author":"DM Park","year":"2014","unstructured":"Park DM, Kim SH, Park YC, Kang WC, Lee SR, Jung IC. The comparative clinical study of efficacy of Gamisoyo-San (Jiaweixiaoyaosan) on generalized anxiety disorder according to differently manufactured preparations: multicenter, randomized, double blind, placebo controlled trial. J Ethnopharmacol. 2014;158(Pt A):11\u20137.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"19_CR82","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jep.2011.03.023","volume":"135","author":"H-H Chang","year":"2011","unstructured":"Chang H-H, Yi P-L, Cheng C-H, Lu C-Y, Hsiao Y-T, Tsai Y-F, et al. Biphasic effects of baicalin, an active constituent of Scutellaria baicalensis Georgi, in the spontaneous sleep\u2013wake regulation. J Ethnopharmacol. 2011;135(2):359\u201368.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"19_CR83","doi-asserted-by":"publisher","first-page":"207","DOI":"10.26599\/JNR.2019.9040026","volume":"7","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Zhang S, Lui CN, Zhu P, Zhang Z, Lin K, Dai Y, Yung KK. Traditional Chinese medicine-based neurorestorative therapy for Alzheimer\u2019s and Parkinson\u2019s disease. J Neurorestoratology. 2019;7(4):207\u201322.","journal-title":"J Neurorestoratology"},{"key":"19_CR84","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.phymed.2018.04.009","volume":"44","author":"B Gargouri","year":"2018","unstructured":"Gargouri B, Carstensen J, Bhatia HS, Huell M, Dietz GPH, Fiebich BL. Anti-neuroinflammatory effects of Ginkgo biloba extract EGb761 in LPS-activated primary microglial cells. Phytomedicine. 2018;44:45\u201355.","journal-title":"Phytomedicine"},{"issue":"2","key":"19_CR85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1024907918790858","volume":"27","author":"S-T Tsai","year":"2018","unstructured":"Tsai S-T, Huang W-S, Jiang S-K, Liao H-Y. Cervical spinal epidural abscess following needle-knife acupotomy, with an initial presentation that mimicked an acute stroke: a case report. Hong Kong Journal of Emergency Medicine. 2018;27(2):99\u2013102.","journal-title":"Hong Kong Journal of Emergency Medicine"},{"issue":"32","key":"19_CR86","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021345","volume":"99","author":"ST Tsai","year":"2020","unstructured":"Tsai ST, Tseng CH, Lin MC, Liao HY, Teoh BK, San S, et al. Acupuncture reduced the medical expenditure in migraine patients: real-world data of a 10-year national cohort study. Medicine (Baltimore). 2020;99(32):e21345.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"19_CR87","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s11596-019-2065-8","volume":"39","author":"Q Huang","year":"2019","unstructured":"Huang Q, Luo D, Chen L, Liang FX, Chen R. Effectiveness of acupuncture for Alzheimer's disease: an updated systematic review and meta-analysis. Curr Med Sci. 2019;39(3):500\u201311.","journal-title":"Curr Med Sci"},{"issue":"7","key":"19_CR88","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1142\/S0192415X17500732","volume":"45","author":"S Zhou","year":"2017","unstructured":"Zhou S, Dong L, He Y, Xiao H. Acupuncture plus herbal medicine for Alzheimer's disease: a systematic review and meta-analysis. Am J Chin Med. 2017;45(7):1327\u201344.","journal-title":"Am J Chin Med"},{"key":"19_CR89","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fnagi.2020.00098","volume":"12","author":"YY Wang","year":"2020","unstructured":"Wang YY, Yu SF, Xue HY, Li Y, Zhao C, Jin YH. Effectiveness and safety of acupuncture for the treatment of Alzheimer's disease: a systematic review and meta-analysis. Front Aging Neurosci. 2020;12:98.","journal-title":"Front Aging Neurosci"},{"key":"19_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.549772","volume":"14","author":"CC Yu","year":"2020","unstructured":"Yu CC, Du YJ, Wang SQ, Liu LB, Shen F, Wang L, et al. Experimental evidence of the benefits of acupuncture for Alzheimer's disease: an updated review. Front Neurosci. 2020;14:549772.","journal-title":"Front Neurosci"},{"key":"19_CR91","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.12659\/MSM.913858","volume":"25","author":"G Li","year":"2019","unstructured":"Li G, Zeng L, Cheng H, Han J, Zhang X, Xie H. Acupuncture administration improves cognitive functions and alleviates inflammation and nuclear damage by regulating phosphatidylinositol 3 kinase (PI3K)\/Phosphoinositol-dependent kinase 1 (PDK1)\/novel protein kinase C (nPKC)\/Rac 1 signaling pathway in senescence-accelerated prone 8 (SAM-P8) mice. Med Sci Monit. 2019;25:4082\u201393.","journal-title":"Med Sci Monit"},{"key":"19_CR92","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fnins.2019.00037","volume":"13","author":"N Ding","year":"2019","unstructured":"Ding N, Jiang J, Xu A, Tang Y, Li Z. Manual acupuncture regulates behavior and cerebral blood flow in the SAMP8 mouse model of Alzheimer's disease. Front Neurosci. 2019;13:37.","journal-title":"Front Neurosci"},{"key":"19_CR93","doi-asserted-by":"publisher","first-page":"8296824","DOI":"10.1155\/2018\/8296824","volume":"2018","author":"J Jiang","year":"2018","unstructured":"Jiang J, Ding N, Wang K, Li Z. Electroacupuncture could influence the expression of IL-1<i>\u03b2<\/i> and NLRP3 Inflammasome in hippocampus of Alzheimer\u2019s disease animal model. Evid Based Complement Alternat Med. 2018;2018:8296824.","journal-title":"Evid Based Complement Alternat Med"},{"key":"19_CR94","first-page":"692","volume":"43","author":"S-H Tang","year":"2018","unstructured":"Tang S-H, Du Y-J, Xiao J-H, Wang Y, Shen F, Sun G-J. Acupuncture and Moxibustion improves learning-memory ability of Alzheimer's disease rats possibly by up-regulating serum A\u03b2 internalization enzyme contents. Zhen Ci Yan Jiu. 2018;43:692\u20137.","journal-title":"Zhen Ci Yan Jiu"},{"issue":"1","key":"19_CR95","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12974-019-1665-3","volume":"16","author":"M Cai","year":"2019","unstructured":"Cai M, Lee J-H, Yang EJ. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer\u2019s disease animal model. J Neuroinflammation. 2019;16(1):264.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"19_CR96","doi-asserted-by":"publisher","first-page":"7416","DOI":"10.1038\/s41598-018-25813-x","volume":"8","author":"F Guan","year":"2018","unstructured":"Guan F, Lam W, Hu R, Kim YK, Han H, Cheng Y-C. Majority of Chinese medicine herb category \u201cQing re Yao\u201d have multiple mechanisms of anti-inflammatory activity. Sci Rep. 2018;8(1):7416.","journal-title":"Sci Rep"},{"issue":"3","key":"19_CR97","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13760-017-0816-5","volume":"117","author":"E Niemantsverdriet","year":"2017","unstructured":"Niemantsverdriet E, Valckx S, Bjerke M, Engelborghs S. Alzheimer's disease CSF biomarkers: clinical indications and rational use. Acta Neurol Belg. 2017;117(3):591\u2013602.","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"19_CR98","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.biocel.2004.07.009","volume":"37","author":"EE Tuppo","year":"2005","unstructured":"Tuppo EE, Arias HR. The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol. 2005;37(2):289\u2013305.","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"19_CR99","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/jir.2013.0085","volume":"34","author":"M Belkhelfa","year":"2014","unstructured":"Belkhelfa M, Rafa H, Medjeber O, Arroul-Lammali A, Behairi N, Abada-Bendib M, et al. IFN-\u03b3 and TNF-\u03b1 are involved during Alzheimer disease progression and correlate with nitric oxide production: a study in Algerian patients. J Interferon Cytokine Res. 2014;34(11):839\u201347.","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"19_CR100","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview. Mol Neurobiol. 2014;50(2):534\u201344.","journal-title":"Mol Neurobiol"},{"issue":"12","key":"19_CR101","first-page":"8342","volume":"7","author":"C Liu","year":"2014","unstructured":"Liu C, Cui G, Zhu M, Kang X, Guo H. Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors. Int J Clin Exp Pathol. 2014;7(12):8342\u201355.","journal-title":"Int J Clin Exp Pathol"},{"key":"19_CR102","doi-asserted-by":"publisher","DOI":"10.1100\/2012\/756357","volume":"2012","author":"JM Rubio-Perez","year":"2012","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. ScientificWorldJournal. 2012;2012:756357.","journal-title":"ScientificWorldJournal"},{"issue":"10","key":"19_CR103","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanct\u00f4t K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer's disease. Biol Psychiatry. 2010;68(10):930\u201341.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"19_CR104","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10072-014-2008-x","volume":"36","author":"SM Chiou","year":"2015","unstructured":"Chiou SM, Lin YC, Lu MK, Tsai CH. Bilateral subthalamic stimulation for advanced Parkinson disease: early experience at an eastern center. Neurol Sci. 2015;36(4):515\u201320.","journal-title":"Neurol Sci"},{"issue":"6","key":"19_CR105","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","volume":"16","author":"EK Tan","year":"2020","unstructured":"Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics. Nat Rev Neurol. 2020;16(6):303\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"19_CR106","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1515\/revneuro-2017-0108","volume":"29","author":"M Amanat","year":"2018","unstructured":"Amanat M, Salehi M, Rezaei N. Neurological and psychiatric disorders in psoriasis. Rev Neurosci. 2018;29(7):805\u201313.","journal-title":"Rev Neurosci"},{"issue":"1","key":"19_CR107","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07853890.2017.1412088","volume":"50","author":"CC Chang","year":"2018","unstructured":"Chang CC, Lin TM, Chang YS, Chen WS, Sheu JJ, Chen YH, et al. Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan. Ann Med. 2018;50(1):83\u201390.","journal-title":"Ann Med"},{"issue":"14","key":"19_CR108","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014984","volume":"98","author":"UH Ju","year":"2019","unstructured":"Ju UH, Liu FC, Lin CS, Huang WY, Lin TY, Shen CH, et al. Risk of Parkinson disease in Sj\u00f6gren syndrome administered ineffective immunosuppressant therapies: a nationwide population-based study. Medicine (Baltimore). 2019;98(14):e14984.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"19_CR109","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jaad.2019.07.012","volume":"83","author":"JH Lee","year":"2020","unstructured":"Lee JH, Han K, Gee HY. The incidence rates and risk factors of Parkinson disease in patients with psoriasis: a nationwide population-based cohort study. J Am Acad Dermatol. 2020;83(6):1688\u201395.","journal-title":"J Am Acad Dermatol"},{"issue":"1\u20134","key":"19_CR110","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000333222","volume":"10","author":"X Li","year":"2012","unstructured":"Li X, Sundquist J, Sundquist K. Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis. 2012;10(1\u20134):277\u201384.","journal-title":"Neurodegener Dis"},{"issue":"18","key":"19_CR111","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1212\/WNL.0b013e3181c06635","volume":"73","author":"K Rugbjerg","year":"2009","unstructured":"Rugbjerg K, Friis S, Ritz B, Schernhammer ES, Korbo L, Olsen JH. Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology. 2009;73(18):1462\u20138.","journal-title":"Neurology"},{"issue":"6","key":"19_CR112","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.jaad.2012.12.961","volume":"68","author":"JJ Sheu","year":"2013","unstructured":"Sheu JJ, Wang KH, Lin HC, Huang CC. Psoriasis is associated with an increased risk of parkinsonism: a population-based 5-year follow-up study. J Am Acad Dermatol. 2013;68(6):992\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"19_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175836","volume":"12","author":"MC Wu","year":"2017","unstructured":"Wu MC, Xu X, Chen SM, Tyan YS, Chiou JY, Wang YH, et al. Impact of Sjogren's syndrome on Parkinson\u2019s disease: a nationwide case-control study. PLoS One. 2017;12(7):e0175836.","journal-title":"PLoS One"},{"issue":"7","key":"19_CR114","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/acn3.580","volume":"5","author":"BA Racette","year":"2018","unstructured":"Racette BA, Gross A, Vouri SM, Camacho-Soto A, Willis AW, Searles NS. Immunosuppressants and risk of Parkinson disease. Ann Clin Transl Neurol. 2018;5(7):870\u20135.","journal-title":"Ann Clin Transl Neurol"},{"issue":"37","key":"19_CR115","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012172","volume":"97","author":"L Ren","year":"2018","unstructured":"Ren L, Yi J, Yang J, Li P, Cheng X, Mao P. Nonsteroidal anti-inflammatory drugs use and risk of Parkinson disease: a dose-response meta-analysis. Medicine (Baltimore). 2018;97(37):e12172.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"19_CR116","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/BF00689592","volume":"76","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, McGeer EG. Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol. 1988;76(6):550\u20137.","journal-title":"Acta Neuropathol"},{"key":"19_CR117","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","volume":"327","author":"MN Karpenko","year":"2018","unstructured":"Karpenko MN, Vasilishina AA, Gromova EA, Muruzheva ZM, Miliukhina IV, Bernadotte A. Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease. Cell Immunol. 2018;327:77\u201382.","journal-title":"Cell Immunol"},{"issue":"1","key":"19_CR118","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M Mogi","year":"1996","unstructured":"Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci Lett. 1996;211(1):13\u20136.","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"19_CR119","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci Lett. 1994;165(1\u20132):208\u201310.","journal-title":"Neurosci Lett"},{"key":"19_CR120","first-page":"143","volume":"58","author":"T Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A. Cytokines in Parkinson\u2019s disease. J Neural Transm Suppl. 2000;58:143\u201351.","journal-title":"J Neural Transm Suppl"},{"issue":"1","key":"19_CR121","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/aje\/kwm260","volume":"167","author":"H Chen","year":"2008","unstructured":"Chen H, O'Reilly EJ, Schwarzschild MA, Ascherio A. Peripheral inflammatory biomarkers and risk of Parkinson\u2019s disease. Am J Epidemiol. 2008;167(1):90\u20135.","journal-title":"Am J Epidemiol"},{"key":"19_CR122","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fnins.2019.00255","volume":"13","author":"TH Lian","year":"2019","unstructured":"Lian TH, Guo P, Zuo LJ, Hu Y, Yu SY, Yu QJ, et al. Tremor-dominant in Parkinson disease: the relevance to iron metabolism and inflammation. Front Neurosci. 2019;13:255.","journal-title":"Front Neurosci"},{"key":"19_CR123","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","volume":"9","author":"JB Schr\u00f6der","year":"2018","unstructured":"Schr\u00f6der JB, Pawlowski M, Meyer Zu H\u00f6rste G, Gross CC, Wiendl H, Meuth SG, et al. Immune cell activation in the cerebrospinal fluid of patients with Parkinson\u2019s disease. Front Neurol. 2018;9:1081.","journal-title":"Front Neurol"},{"key":"19_CR124","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3389\/fneur.2018.00870","volume":"9","author":"RS Wijeyekoon","year":"2018","unstructured":"Wijeyekoon RS, Kronenberg-Versteeg D, Scott KM, Hayat S, Jones JL, Clatworthy MR, et al. Monocyte function in Parkinson\u2019s disease and the impact of autologous serum on phagocytosis. Front Neurol. 2018;9:870.","journal-title":"Front Neurol"},{"key":"19_CR125","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","volume":"300","author":"AS Harms","year":"2018","unstructured":"Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, et al. Peripheral monocyte entry is required for Alpha-synuclein induced inflammation and neurodegeneration in a model of Parkinson disease. Exp Neurol. 2018;300:179\u201387.","journal-title":"Exp Neurol"},{"issue":"2","key":"19_CR126","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009399","volume":"2","author":"L Stefanis","year":"2012","unstructured":"Stefanis L. \u03b1-Synuclein in Parkinson\u2019s disease. Cold Spring Harb Perspect Med. 2012;2(2):a009399.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"19_CR127","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","volume":"3","author":"DA Cook","year":"2017","unstructured":"Cook DA, Kannarkat GT, Cintron AF, Butkovich LM, Fraser KB, Chang J, et al. LRRK2 levels in immune cells are increased in Parkinson\u2019s disease. Npj Parkinson\u2019s Disease. 2017;3(1):11.","journal-title":"Npj Parkinson\u2019s Disease"},{"issue":"1","key":"19_CR128","doi-asserted-by":"publisher","first-page":"15446","DOI":"10.1038\/s41598-018-33921-x","volume":"8","author":"F Atashrazm","year":"2018","unstructured":"Atashrazm F, Hammond D, Perera G, Dobson-Stone C, Mueller N, Pickford R, et al. Reduced glucocerebrosidase activity in monocytes from patients with Parkinson\u2019s disease. Sci Rep. 2018;8(1):15446.","journal-title":"Sci Rep"},{"issue":"5","key":"19_CR129","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo P, Dodiya HB, Engen PA, Forsyth CB, Huschens AM, Shaikh M, et al. Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut. 2019;68(5):829\u201343.","journal-title":"Gut"},{"issue":"2","key":"19_CR130","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis. 2006;21(2):404\u201312.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"19_CR131","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch EC, Hunot S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 2009;8(4):382\u201397.","journal-title":"Lancet Neurol"},{"key":"19_CR132","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/bs.irn.2018.08.009","volume":"141","author":"AA Roussakis","year":"2018","unstructured":"Roussakis AA, Piccini P. Molecular imaging of Neuroinflammation in idiopathic Parkinson\u2019s disease. Int Rev Neurobiol. 2018;141:347\u201363.","journal-title":"Int Rev Neurobiol"},{"issue":"423","key":"19_CR133","doi-asserted-by":"publisher","first-page":"eaai7795","DOI":"10.1126\/scitranslmed.aai7795","volume":"10","author":"KY Hui","year":"2018","unstructured":"Hui KY, Fernandez-Hernandez H, Hu J, Schaffner A, Pankratz N, Hsu N-Y, et al. Functional variants in the <em>LRRK2<\/em> gene confer shared effects on risk for Crohn\u2019s disease and Parkinson\u2019s disease. Sci Transl Med. 2018;10(423):eaai7795.","journal-title":"Sci Transl Med"},{"issue":"2","key":"19_CR134","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00401-018-1943-7","volume":"137","author":"A Prigent","year":"2019","unstructured":"Prigent A, Lionnet A, Durieu E, Chapelet G, Bourreille A, Neunlist M, et al. Enteric alpha-synuclein expression is increased in Crohn's disease. Acta Neuropathol. 2019;137(2):359\u201361.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"19_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007329","volume":"14","author":"MA Rivas","year":"2018","unstructured":"Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, et al. Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genet. 2018;14(5):e1007329.","journal-title":"PLoS Genet"},{"issue":"9","key":"19_CR136","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1134\/S0006297918090122","volume":"83","author":"MP Aliseychik","year":"2018","unstructured":"Aliseychik MP, Andreeva TV, Rogaev EI. Immunogenetic factors of neurodegenerative diseases: the role of HLA class II. Biochemistry (Mosc). 2018;83(9):1104\u201316.","journal-title":"Biochemistry (Mosc)"},{"issue":"15","key":"19_CR137","doi-asserted-by":"publisher","first-page":"7419","DOI":"10.1073\/pnas.1821778116","volume":"116","author":"JA Hollenbach","year":"2019","unstructured":"Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, et al. A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2019;116(15):7419\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"19_CR138","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA. 2020;323(6):548\u201360.","journal-title":"JAMA"},{"issue":"1","key":"19_CR139","doi-asserted-by":"publisher","first-page":"20","DOI":"10.17925\/ENR.2016.11.01.20","volume":"11","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Fleisher JE. Reaching those most in need\u2014a call to action for advanced Parkinson\u2019s disease. Eur Neurol Rev. 2016;11(1):20\u20131.","journal-title":"Eur Neurol Rev"},{"issue":"5","key":"19_CR140","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1212\/WNL.57.5.790","volume":"57","author":"PR Rajendran","year":"2001","unstructured":"Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson\u2019s disease. Neurology. 2001;57(5):790\u20134.","journal-title":"Neurology"},{"issue":"3","key":"19_CR141","first-page":"536","volume":"33","author":"J-M Shim","year":"2016","unstructured":"Shim J-M, Kim J. Cross-national differences in the holistic use of traditional east Asian medicine in East Asia. Health Promot Int. 2016;33(3):536\u201344.","journal-title":"Health Promot Int"},{"issue":"9","key":"19_CR142","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, et al. Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord. 2017;32(9):1264\u2013310.","journal-title":"Mov Disord"},{"issue":"7647","key":"19_CR143","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1136\/bmj.39527.472303.4E","volume":"336","author":"J Curran","year":"2008","unstructured":"Curran J. The yellow Emperor\u2019s classic of internal medicine. BMJ. 2008;336(7647):777.","journal-title":"BMJ"},{"key":"19_CR144","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3389\/fphar.2017.00634","volume":"8","author":"X Li","year":"2017","unstructured":"Li X, Zhang Y, Wang Y, Xu J, Xin P, Meng Y, et al. The mechanisms of traditional Chinese medicine underlying the prevention and treatment of Parkinson\u2019s disease. Front Pharmacol. 2017;8:634.","journal-title":"Front Pharmacol"},{"issue":"5","key":"19_CR145","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/S0254-6272(17)30324-2","volume":"37","author":"H Chen","year":"2017","unstructured":"Chen H, Zhang Z, He J, Teng L, Yuan C. Traditional Chinese medicine symptom pattern analysis for Parkinson\u2019s disease. J Tradit Chin Med. 2017;37(5):688\u201394.","journal-title":"J Tradit Chin Med"},{"issue":"5","key":"19_CR146","first-page":"447","volume":"7","author":"C Sheng-d","year":"2007","unstructured":"Sheng-d C. The protection of curcumin in nigral dopaminergic neuronal injury of mice model of Parkinson disease. Chin J Contemp Neurol Neurosurg. 2007;7(5):447\u201352.","journal-title":"Chin J Contemp Neurol Neurosurg"},{"issue":"1","key":"19_CR147","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2202-10-109","volume":"10","author":"K Faust","year":"2009","unstructured":"Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B. Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a drosophila model of Parkinson\u2019s disease. BMC Neurosci. 2009;10(1):109.","journal-title":"BMC Neurosci"},{"issue":"9","key":"19_CR148","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/mds.20503","volume":"20","author":"A Cristian","year":"2005","unstructured":"Cristian A, Katz M, Cutrone E, Walker RH. Evaluation of acupuncture in the treatment of Parkinson\u2019s disease: a double-blind pilot study. Mov Disord. 2005;20(9):1185\u20138.","journal-title":"Mov Disord"},{"key":"19_CR149","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3389\/fneur.2020.00917","volume":"11","author":"J Huang","year":"2020","unstructured":"Huang J, Qin X, Cai X, Huang Y. Effectiveness of acupuncture in the treatment of Parkinson\u2019s disease: an overview of systematic reviews. Front Neurol. 2020;11:917.","journal-title":"Front Neurol"},{"issue":"5","key":"19_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019790","volume":"6","author":"H Wang","year":"2011","unstructured":"Wang H, Pan Y, Xue B, Wang X, Zhao F, Jia J, et al. The antioxidative effect of electro-acupuncture in a mouse model of Parkinson\u2019s disease. PLoS One. 2011;6(5):e19790.","journal-title":"PLoS One"},{"issue":"1","key":"19_CR151","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.brainres.2006.10.089","volume":"1131","author":"JM Kang","year":"2007","unstructured":"Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, et al. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res. 2007;1131(1):211\u20139.","journal-title":"Brain Res"},{"key":"19_CR152","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/908439","volume":"2012","author":"LR Huo","year":"2012","unstructured":"Huo LR, Liang XB, Li B, Liang JT, He Y, Jia YJ, et al. The cortical and striatal gene expression profile of 100\u2009hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson\u2019s disease model. Evid Based Complement Alternat Med. 2012;2012:908439.","journal-title":"Evid Based Complement Alternat Med"},{"key":"19_CR153","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.parkreldis.2018.11.014","volume":"59","author":"G Chapelet","year":"2019","unstructured":"Chapelet G, Leclair-Visonneau L, Clairembault T, Neunlist M, Derkinderen P. Can the gut be the missing piece in uncovering PD pathogenesis? Parkinsonism Relat Disord. 2019;59:26\u201331.","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"19_CR154","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease\u2014the gut-brain axis and environmental factors. Nat Rev Neurol. 2015;11(11):625\u201336.","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"19_CR155","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, R\u00fcb U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm (Vienna). 2003;110(5):517\u201336.","journal-title":"J Neural Transm (Vienna)"},{"issue":"6","key":"19_CR156","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","volume":"33","author":"CH Hawkes","year":"2007","unstructured":"Hawkes CH, Del Tredici K, Braak H. Parkinson\u2019s disease: a dual-hit hypothesis. Neuropathol Appl Neurobiol. 2007;33(6):599\u2013614.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"19_CR157","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627\u201341.e7.","journal-title":"Neuron"},{"issue":"4","key":"19_CR158","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horv\u00e1th-Puh\u00f3 E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78(4):522\u20139.","journal-title":"Ann Neurol"},{"key":"19_CR159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.002","volume":"38","author":"A Parashar","year":"2017","unstructured":"Parashar A, Udayabanu M. Gut microbiota: implications in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;38:1\u20137.","journal-title":"Parkinsonism Relat Disord"},{"key":"19_CR160","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJ, Kraneveld AD. Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol. 2017;8:37.","journal-title":"Front Neurol"},{"key":"19_CR161","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2017.02.029","volume":"39","author":"A Su","year":"2017","unstructured":"Su A, Gandhy R, Barlow C, Triadafilopoulos G. A practical review of gastrointestinal manifestations in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;39:17\u201326.","journal-title":"Parkinsonism Relat Disord"},{"key":"19_CR162","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, et al. Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis. 2013;50:42\u20138.","journal-title":"Neurobiol Dis"},{"issue":"1","key":"19_CR163","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"C-H Lin","year":"2019","unstructured":"Lin C-H, Chen C-C, Chiang H-L, Liou J-M, Chang C-M, Lu T-P, et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J Neuroinflammation. 2019;16(1):129.","journal-title":"J Neuroinflammation"},{"issue":"22","key":"19_CR164","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.1002\/pmic.200700955","volume":"8","author":"S Jeon","year":"2008","unstructured":"Jeon S, Kim YJ, Kim ST, Moon W, Chae Y, Kang M, et al. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson\u2019s disease mouse model. Proteomics. 2008;8(22):4822\u201332.","journal-title":"Proteomics"},{"issue":"11","key":"19_CR165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027566","volume":"6","author":"SN Kim","year":"2011","unstructured":"Kim SN, Doo AR, Park JY, Bae H, Chae Y, Shim I, et al. Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson\u2019s disease. PLoS One. 2011;6(11):e27566.","journal-title":"PLoS One"},{"issue":"10","key":"19_CR166","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3109\/00207454.2011.591515","volume":"121","author":"SN Kim","year":"2011","unstructured":"Kim SN, Kim ST, Doo AR, Park JY, Moon W, Chae Y, et al. Phosphatidylinositol 3-kinase\/Akt signaling pathway mediates acupuncture-induced dopaminergic neuron protection and motor function improvement in a mouse model of Parkinson\u2019s disease. Int J Neurosci. 2011;121(10):562\u20139.","journal-title":"Int J Neurosci"},{"issue":"1","key":"19_CR167","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0014-4886(02)00031-6","volume":"180","author":"HJ Park","year":"2003","unstructured":"Park HJ, Lim S, Joo WS, Yin CS, Lee HS, Lee HJ, et al. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson\u2019s disease model. Exp Neurol. 2003;180(1):93\u20138.","journal-title":"Exp Neurol"},{"issue":"10","key":"19_CR168","doi-asserted-by":"publisher","first-page":"7706","DOI":"10.1007\/s12035-016-0258-8","volume":"54","author":"J-Y Park","year":"2017","unstructured":"Park J-Y, Kim S-N, Yoo J, Jang J, Lee A, Oh J-Y, et al. Novel neuroprotective effects of melanin-concentrating hormone in Parkinson\u2019s disease. Mol Neurobiol. 2017;54(10):7706\u201321.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"19_CR169","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.bbrc.2015.03.105","volume":"460","author":"JY Park","year":"2015","unstructured":"Park JY, Choi H, Baek S, Jang J, Lee A, Jeon S, et al. p53 signalling mediates acupuncture-induced neuroprotection in Parkinson\u2019s disease. Biochem Biophys Res Commun. 2015;460(3):772\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"19_CR170","first-page":"1336","volume":"24","author":"S-T Tsai","year":"2021","unstructured":"Tsai S-T, Wei T-H, Yang Y-W, Lu M-K, San S, Tsai C-H, et al. Transient receptor potential V1 modulates neuroinflammation in Parkinson\u2019s disease dementia: molecular implications for electroacupuncture and rivastigmine. Iran J Basic Med Sci. 2021;24(10):1336\u201345.","journal-title":"Iran J Basic Med Sci"},{"issue":"3","key":"19_CR171","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.3479","volume":"20","author":"R Torres-Rosas","year":"2014","unstructured":"Torres-Rosas R, Yehia G, Pe\u00f1a G, Mishra P, del Rocio T-BM, Moreno-Eutimio MA, et al. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med. 2014;20(3):291\u20135.","journal-title":"Nat Med"},{"key":"19_CR172","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2020.08.015","volume":"89","author":"J-H Jang","year":"2020","unstructured":"Jang J-H, Yeom M-J, Ahn S, Oh J-Y, Ji S, Kim T-H, et al. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson\u2019s disease. Brain Behav Immun. 2020;89:641\u201355.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"19_CR173","first-page":"964","volume":"17","author":"L Kouti","year":"2013","unstructured":"Kouti L, Noroozian M, Akhondzadeh S, Abdollahi M, Javadi MR, Faramarzi MA, et al. Nitric oxide and peroxynitrite serum levels in Parkinson\u2019s disease: correlation of oxidative stress and the severity of the disease. Eur Rev Med Pharmacol Sci. 2013;17(7):964\u201370.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-19-7376-5_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T19:07:40Z","timestamp":1679512060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-19-7376-5_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789811973758","9789811973765"],"references-count":173,"URL":"https:\/\/doi.org\/10.1007\/978-981-19-7376-5_19","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"23 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}